Poster Abstract Session:
225. Clinical Practice Issues: HIV, Sepsis, QI, Diagnosis
Saturday, October 6, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Pediatric ID, HIV-STD-TB, Adult ID


Presentations:
Cost Minimisation Analysis of a Preferred ARV Prescribing Pathway for Treatment-Naïve HIV-Positive Patients
Colm Kerr, MB BCh BAO MRCPI BSc Microbiology; Niamh Allen, MB BCh BAO MRCPI; David Moynan, MB BCh BAO MRCPI; Miriam Moriarty, Pharmacist; Sinead Murphy, CNS; Gillian Farrell, Clinical Nurse Specialist; Colm Bergin, MD, FRCPI
Posters
  • ID Week Cost Minimisation.pdf (574.2 kB)
  • Impact of Mail Order Pharmacy Use on Viral Suppression Among HIV-Infected Patients
    Justine Choe, PharmD; Cynthia Nguyen, PharmD; Natasha N Pettit, PharmD; Jessica P. Ridgway, MD, MS
    Posters
  • ID Week Final.pdf (427.4 kB)
  • Real-World Insights into Quality Improvement across 11 HIV Clinics in the US
    David Alain Wohl, MD; Cynthia Brinson, M.D.; Charles Hicks, MD; Peter Shalit, MD, PhD; W. David Hardy, MD; Jeffrey Carter, PhD; Laura Simone, PhD; Tamar Sapir, PhD
    Hospitalization Rates among Persons with HIV Who Gained Medicaid or Private Insurance in 2014
    Jeremy Chow, MD, MS; Ank Nijhawan, MD, MPH, MSCS; Julia Raifman, ScD; Kelly Gebo, MD, MPH, FIDSA; Richard Moore, MD, MHS, FIDSA; Stephen Berry, MD, PhD
    Posters
  • ID week 2018 poster ChowJY3.pdf (815.7 kB)
  • Barriers at the Last Hurdle: Implementing Advance Care Planning for People Living with HIV
    Brenda Mae Salada, MD; Siew Fai Lee, Degree (Honours) in Psychology; Clarisse Chen, Bachelor of Psychology; James S Molton, MBBS; Sophia Archuleta, MD; Jessica Michaels, Bachelor of Social Work, Masters of Policy Studies
    Posters
  • Abstract_1907.pdf (687.3 kB)
  • Development of an Electronic Health Record Generated Alert for Prophylaxis Against Pneumocystis Jirovecii Pneumonia in the Setting of High Dose Steroids
    Noopur Goyal, MD; Eric Gaskill, PharmD; Stephanie Sanders, PharmD; Kencee Graves, MD; Russell Benefield, Pharm.D., BCPS (AQ-ID); David ElHalta, RPh, MS; Nicholas C. Link, PharmD, MS; Paloma Cariello, MD, MPH
    Posters
  • PJP Poster ID Week .pdf (392.1 kB)
  • Developing a multi-disciplinary team for infective endocarditis – a quality improvement project
    Archana Vasudevan, MD; Kapil Vyas, DO; Li-Chien Chen, DO; Jane Terhune, RRT; Stevan Whitt, MD; Hariharan Regunath, MD
    Posters
  • ID week poster - Final.pdf (330.8 kB)
  • Implementation of Diabetes Medication Management by Pharmacists in a Multidisciplinary Limb-Salvage Clinic
    Molly Rockstad, PharmD, BCPS, BCACP; Tomasz Jurga, PharmD; Sophia Choi, PA; Katayoun Rezai, MD
    Posters
  • IDweekPoster1911.pdf (463.7 kB)
  • Implementation of Sepsis-3 Definition in the Emergency Department: Proposed of Case Detection in Real-Life Practice
    Pasri Maharom, MD, MPH; Thammasin Inviya, MD, PhD; Sorapop Pakdeewongse, M.D.; Aungsumalin Sricharoon, BNS; Kaimuk Thongyen, BNS; Chirapan Tantimongkolsuk, MD
    Posters
  • IDWeek-2018 poster.pdf (226.3 kB)
  • Clinical Performance of the qSOFA Score Among Non-ICU Inpatients with Infection at a Tertiary Hospital in Jamaica from 2015 To 2016
    Schade' Stanton, MBBS; Tamara Thompson, BSc, MBBS, DM; Trevor Ferguson, MBBS, DM, MSc
    Posters
  • IDw POSTER3.pdf (569.1 kB)
  • Adherence to the Sepsis Bundle in Hospital-Onset v. Community-Onset Sepsis
    Jonathan Baghdadi, MD; Daniel Z. Uslan, MD, MS, FIDSA, FSHEA; Douglas Bell, MD, PhD; Mitchell Wong, MD, PhD
    Predicting real-time risk of complications in the postoperative setting with temperature as a single variable
    Katherine Kaplar, D.O.; Urmila Ravichandran, MS; Ronak Parikh, DO; Eric Bhaimia, D.O.; Elias Baied, DO; Frances Lahrman, DO; Huma Saeed, M.D.; Jennifer Paruch, MD; Rema Padman, PhD; Nirav Shah, MD, MPH; Jennifer Grant, MD
    Diagnostic Stewardship in Infectious Diseases Molecular Viral Testing: A Pilot Project
    Gabriela Corsi, MD; Audrey Wanger, PhD; Karen James, BBA; Brian Banner, BBA; Bela Patel, MD; Jeffrey Katz, MD; Luis Ostrosky-Zeichner, MD, FIDSA, FSHEA
    Diagnostic Errors in Bacterial Osteomyelitis in Children
    Yuki Otani, MD; Yuta Aizawa, MD, PhD; Hiroshi Hataya, MD; Yuho Horikoshi, MD
    Is it time to assess the role of blood cultures in the current practice of medicine?
    Ali Nadhim, M.D; John R Middleton, MD, MACP, FIDSA; Nazar Raoof, MD; Iyengar Uma, BSEE, MSEE; Emily Tutino, MS
    Ocular Involvement in Candidemia Patients at an Urban Tertiary Care Center: Is Inpatient Ophthalmologic Consultation Essential?
    Robert Brunner, DO; Zaw Min, M.D, FACP; Rasha Abdulmassih, MD; Nitin Bhanot, MD, MPH
    The Challenges of Caring for People Who Inject Drugs – an Opportunity for an Infectious Diseases Service
    Anna C. Riddell, MA (Oxon), MRCP, DTM&H; Emma McGuire, MRCP, DTM&H; Maximillian S. Habibi, PhD, MRCP, FRCPath
    Posters
  • PWID_IDSA2018.pdf (509.8 kB)
  • OPAT or no-PAT? Evaluation of Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Daptomycin or Ertapenem for “Ease of Administration”
    Rachel S. Britt, PharmD; Mary T. Lasalvia, MD, MPH; Simi Padival, MD; Parth V. Patel, RN; Christopher McCoy, PharmD, BCPS-AQ ID; Monica V. Mahoney, PharmD, BCPS-AQ ID
    Posters
  • Britt IDWeek Poster Draft 3.pdf (390.6 kB)
  • Vancomycin Treatment and Time to Adverse Drug Reactions during Outpatient Parenteral Antimicrobial Therapy (OPAT)
    Asajah Duncan, PharmD; Alan Kinlaw, PhD; Vahini Chundi, MD; Claire Farel, MD, MPH; Ashley Marx, PharmD
    Posters
  • Vanc ID Week 2018.pdf (379.5 kB)
  • Evaluation of Safety and Effectiveness of Continuous Infusion Ceftolozane/Tazobactam as Outpatient Parenteral Antimicrobial Therapy
    Bruce M Jones, PharmD, BCPS; Kathryn Huelfer, PharmD Candidate; Melissa Wynn, MD; Henry N Young, PhD; Christopher Bland, PharmD, BCPS, FIDSA
    Posters
  • 1926_IDWPOSTER.pdf (641.5 kB)
  • Preference for Intravenous Versus Oral Antibiotics at Hospital Discharge
    Anthony Karabanow, MD; Geneve Allison, MD, MSc; Shira Doron, MD, MS, FIDSA
    Posters
  • 1927_IDWPOSTER.pdf (965.8 kB)
  • Risk of Acute Kidney Injury in Combat-Injured Patients Associated with Concomitant Vancomycin and Extended-Spectrum β-Lactam Antibiotic Use
    Joseph Yabes Jr., MD; Laveta Stewart, PhD, MSc, MPH; Faraz Shaikh, MS; Dan Z. Lu, MS; Teresa Merritt, BS; Katrin Mende, PhD; Leigh Carson, MS; Paul M. Robben, MD/PhD; Robert Leimbach, MD; Joseph L. Petfield, MD; Anuradha Ganesan, MD, MPH; David R. Tribble, MD, DrPH; Dana M. Blyth, MD

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.